Pediatric IgA nephropathies: Clinical aspects and therapeutic approaches

Seminars in Nephrology

Volumn 24, Issue 3, 2004, Pages 269-286

  Delos Santos, Noel M ^a   Wyatt, Robert J ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b LE BONHEUR CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; BENAZEPRIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; FISH OIL; HEPARIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; UROKINASE; WARFARIN;

ANAPHYLACTOID PURPURA; CLINICAL FEATURE; CLINICAL TRIAL; EPIDEMIOLOGICAL DATA; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; TONSILLECTOMY;

EID: 2542426715     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2004.01.007     Document Type: Article

References (162)

1. D'Amico G: The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 64:709-727, 1987
2. Utsunomiya Y, Kado T, Koda T, et al: Features of IgA nephropathy in preschool children. Clin Nephrol 54:443-448, 2000
3. Yoshikawa N, Tanaka R, Iijima K: Pathophysiology and treatment of IgA nephropathy in children. Pediatr Nephrol 16:446-457, 2001
4. Cho BS, Kim SD, Choi YM, et al: School urinalysis screening in Korea: Prevalence of chronic renal disease. Pediatr Nephrol 16:1126-1128, 2001
5. Wyatt RJ, Julian BA, Baehler RW, et al: Epidemiology of IgA nephropathy in central and eastern Kentucky for the period 1975 through 1994. J Am Soc Nephrol 9:853-858, 1998
6. Clarkson AR: IgA nephropathy: History, classification, and geographical distribution, in Clarkson AR, (ed): IgA Nephropathy. Boston, Martinus Nijhoff, 1987, pp 1-8
7. Jennette JC, Wall SD, Wilkman AS: Low incidence of IgA nephropathy in blacks. Kidney Int 28:944-950, 1985
8. Seedat YK, Nathoo BC, Parag KB, et al: IgA nephropathy in blacks and Indians of Natal. Nephron 50:137-141, 1988
9. Oviasu E: IgA nephropathy (IgAN) presenting with the nephritic syndrome. Trop Geogr Med 44:365-368, 1992
10. Sehic AM, Gaber LW, Roy S III, et al: Increased recognition of IgA nephropathy in African-American children. Pediatr Nephrol 11:435-437, 1997
11. Utsunomiya Y, Koda T, Kado T, et al: Incidence of pediatric IgA nephropathy. Pediatr Nephrol 18:511-515, 2003
12. Berger J: IgA glomerular deposits in renal disease. Transplant Proc, 1:939-944, 1968
13. Levy M, Beaufils H, Gubler MC, et al: Idiopathic recurrent macroscopic hematuria and mesangial IgA-IgG deposits in children (Berger's disease). Clin Nephrol 1:63-69, 1973
14. Wyatt RJ, Julian BA, Bhathena DB, et al: IgA nephropathy: Presentation, clinical course and prognosis in children and adults. Am J Kidney Dis 4:192-200, 1984
15. Kher KK, Makker SP, Moorthy B: IgA nephropathy (Berger's disease) - A clinicopathologic study in children. Int J Pediatr Nephrol 4:11-18, 1983
16. Levy M, Gonzalez-Burchard G, Broyer M, et al: Berger's disease in children. Medicine 64:157-180, 1985
17. Berg UB: Long-term follow up of renal function in IgA nephropathy. Arch Dis Child 66:588-592, 1991
18. Southwest Pediatric Nephrology Study Group: A multicenter study of IgA nephropathy in children. Kidney Int 22:643-652, 1982
19. Hogg RJ, Silva FG, Wyatt RJ, et al: Prognostic indicators in children with IgA nephropathy: Report of the Southwest Pediatric Nephrology Study Group. Pediatr Nephrol 8:15-20, 1994
20. Wyatt RJ, Kritchevsky SB, Woodford SY, et al: IgA nephropathy: Long-term prognosis for pediatric patients. J Pediatr 127:913-919, 1995
21. Kitajima T, Murakami M, Sakai O: Clinicopathological features in Japanese patients with IgA nephropathy. Jpn J Med 22:219-222, 1983
22. Kusomoto Y, Takebayashi S, Taguchi T, et al: Long-term prognosis and prognostic indices of IgA nephropathy in juvenile and adult Japanese. Clin Nephrol 28:118-124, 1987
23. Yoshikawa N, Ito H, Yoshiara S, et al: Clinical course of immunoglobulin A nephropathy in children. J Pediatr 110:555-560, 1987
24. Yoshikawa N, Ito H, Nakamura H: IgA nephropathy in children from Japan. Child Nephrol Urol 9:191-199, 1989
25. Yoshikawa N, Ito H, Nakamura H: Prognostic indicators in childhood IgA nephropathy. Nephron 60:60-67, 1992
26. Hisano S, Kawano M, Kaku Y, et al: The natural history of screening detected IgA glomerulonephritis in children. Acta Pediatr Scand 80:1044-1050, 1991
27. Stapleton FB, Roy S III, Noe HN, Jerkins G: Hypercalciuria in children with hematuria. N Engl J Med 310:1345-1348, 1984
28. Tasic V, Korneti P, Ristoska-Bojkovska, et al: Idiopathic hypercalciuria preceding IgA nephritis in a child with recurrent hematuria. Pediatr Nephrol 18:394-396, 2003
29. Southwest Pediatric Nephrology Study Group: Association of IgA nephropathy with steroid-responsive nephrotic syndrome. Am J Kidney Dis 5:157-164, 1985
30. Wyatt RJ, Hogg RJ: Evidence-based assessment of treatment options for children with IgA nephropathies. Pediatr Nephrol 16:156-167, 2001
31. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute: Report of the Second Task Force on Blood Pressure Control in Children. Pediatrics 58:259-263, 1976
32. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents: Update on the 1987 task force report on high blood pressure in children and adolescents: A working group report from the National High Blood Pressure Education Program. Pediatrics 98:649-658, 1998
33. Delos Santos NM, Ault BH, Gharavi AG, et al: Angiotensin-converting enzyme genotype and outcome in pediatric IgA nephropathy. Pediatr Nephrol 17:496-502, 2002
34. Welch TR, McAdams J, Berry A: Rapidly progressive IgA nephropathy. Am J Dis Child 142:789-793, 1988
35. Radford MG, Donadio JV, Bergstrahl EJ, et al: Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 8:199-207, 1997
36. Haas M: Histological subclassification of IgA nephropathy: A clinicopathologic study of 244 cases. Am J Kidney Dis 29:829-842, 1997
37. McEnery PT, McAdams AJ, West CD: Glomerular morphology, natural history and treatment of children with IgA-IgG mesangial nephropathy, in Kincaid-Smith P, Mathew TH, Becker EL, (eds): Glomerulonephritis: Natural History and Treatment. New York, Wiley, 1972, pp 305-320
38. Michalk D, Waldherr R, Seelig HP, et al: Idiopathic mesangial IgA-glomerulonephritis in childhood: Description of 19 pediatric cases and review of the literature. Eur J Pediatr 134:13-22, 1980
39. Linne T, Aperia A, Broberger O, et al: Course of renal function in IgA glomerulonephritis in children and adolescents. Acta Paediatr Scand 71:735-743, 1982
40. Ariceta G, Gallego N, Lopez-Fernandez Y, et al: Long-term prognosis of childhood IgA nephropathy in adult life. Med Clin (Barc) 116:361-364, 2001
41. D'Amico G: Natural history of idiopathic IgA nephropathy: Role of clinical and histologic prognostic factors. Am J Kidney Dis 36:227-237, 2000
42. Beukhof JR, Ockhuizen T, Halie LM, et al: Subentities within adult primary IgA-nephropathy. Clin Nephrol 22:195-199, 1984
43. Zidar N, Cavic MA, Kenda RB, et al: Effect of intrauterine growth retardation on the clinical course and prognosis of IgA glomerulonephritis in children. Nephron 79:28-32, 1998
44. Lee SMK, Rao VM, Franklin WA, et al: IgA nephropathy: Morphologic predictors of progressive disease. Hum Pathol 13:314-322, 1987
45. Wyatt RJ, Emancipator SN, Kon V, et al: IgA nephropathy Databank: Development of a system for management of renal biopsy acquired data. Am J Kidney Dis 6:817-828, 1997
46. Andreoli SP, Yum MN, Bergstein JM: IgA nephropathy in children: Significance of glomerular basement membrane deposition of IgA. Am J Nephrol 6:28-33, 1986
47. Yoshikawa N, Ito H, Yoshiya K, et al: Henoch-Schönlein nephritis and IgA nephropathy in children: A comparison of clinical course. Clin Nephrol 27:233-237, 1987
48. Toth T, Takebayashi S: Glomerular hypertrophy as a prognostic marker in childhood IgA nephropathy. Nephron 80:285-291, 1998
49. Watanabe T, Kawachi H, Ikezumi Y, et al: Glomerular CD8+ cells predict progression of childhood IgA nephropathy. Pediatr Nephrol 16:561-567, 2001
50. Nagata M, Akioka Y, Tsunoda Y, et al: Macrophages in childhood IgA nephropathy. Kidney Int 48:527-535, 1995
51. Schena FP, D'Altri C, Cerullo G, et al: ACE gene polymorphism and IgA nephropathy: An ethnically homogeneous study and meta-analysis. Kidney Int 60:732-740, 2001
52. Rigat B, Hubert C, Alhenc-Gelas F, et al: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346, 1990
53. Tanaka R, Iijima K, Murakami R, et al: ACE gene polymorphism in childhood IgA: Association with clinicopathologic findings. Am J Kidney Dis 31:774-779, 1998
54. Asano T, Tatsuma N, Yoshida J, et al: Association of angiotensin-converting enzyme gene polymorphism and renal pathology in Japanese children with IgA nephropathy. Clin Nephrol 51:335-340, 1999
55. Maruyama K, Yoshida M, Nishio H, et al: Polymorphisms of renin-angiotensin system genes in childhood IgA nephropathy. Pediatr Nephrol 16:350-355, 2001
56. Shimomura M, Yoshikawa N, Iijima K, et al: Polymorphism of immunoglobulin heavy chain switch region gene in children with severe IgA nephropathy. Clin Nephrol 43:211-215, 1995
57. Tanaka R, Iijima K, Xu H, et al: Role of platelet-activating factor acetylhydrolase gene mutation in Japanese childhood IgA nephropathy. Am J Kidney Dis 34:289-295, 1999
58. Sackett DL: Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 95:2S-4S, 1989
59. Rodicio JL, Alcazar JM, Ruilope LM: Influence of converting enzyme inhibition on glomerular filtration rate and proteinuria. Kidney Int 38:590-594, 1990
60. Heeg JA, de Jong PE, van der Hem GK, et al: Reduction of proteinuria by angiotensin converting enzyme inhibition. Kidney Int 32:78-84, 1987
61. Remuzzi A, Perico N, Sangalli F, et al: ACE inhibition and ANG II receptor blockade improve glomerular size-selectivity in IgA nephropathy. Am J Physiol 276:F457-F466, 1999
62. Nolin L, Courteau M: Management of IgA nephropathy: Evidence-based recommendations. Kidney Int 70:S56-S62, 1999
63. Floege J: Evidence-based recommendations for immunosuppression in IgA nephropathy: Handle with caution. Nephrol Dial Transplant 18:241-245, 2003
64. Hebert LE, Wilmer WA, Falkenhain ME, et al: Reno-protection: One or many therapies? Kidney Int 59:1211-1223, 2001
65. Glassock RJ: Treatment of IgA nephropathy: Status at the end of the millennium. J Nephrol 12:288-296, 1999
66. Julian BA: Treatment of IgA nephropathy. Sem Nephrol 20:277-285, 2000
67. Bhattacharjee R, Filler G: Additive antiproteinuric effect of ACE inhibitor and losartan in IgA nephropathy. Pediatr Nephrol 17:302-304, 2002
68. Hogg RJ, Wyatt RJ: A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy. (submitted)
69. Coppo R, Chiesa M, Peruzzi L, et al: Treatment of IgA nephropathy with angiotensin converting enzyme inhibitors: Design of a prospective randomized multicenter trial. J Nephrol 14:447-452, 2001
70. Itami N, Akutsu Y, Kusunoki Y, et al: Does methylprednisolone pulse therapy deteriorate the course if rapidly progressive IgA nephropathy? Am J Dis Child 143:441-442, 1989
71. Boobes Y, Baz M, Durand C, et al: Early start of intensive therapy in malignant form of IgA nephropathy. Nephron 54:351-353, 1990
72. Niaudet P, Murcia I, Beaufils H, et al: Primary IgA nephropathies in children: Prognosis and treatment. Adv Nephrol 22:121-140, 1993
73. Rocacatello D, Ferro M, Coppo R, et al: Report on intensive treatment of extracapillary glomerulonephritis with focus on crescentic IgA nephropathy. Nephrol Dial Transplant 10:2054-2059, 1995
74. Waldo FB, Alexander R, Wyatt RJ, et al: Alternate-day prednisone therapy in children with IgA-associated nephritis. Am J Kidney Dis 13:55-60, 1989
75. Waldo FB, Wyatt RJ, Kelly DR, et al: Treatment of IgA nephropathy in children: Efficacy of alternate-day oral prednisone. Pediatr Nephrol 7:529-532, 1993
76. Tanaka H, Waga S, Yokoyama M: Age-related histologic alterations after prednisolone therapy in children with IgA nephropathy. Tohoku J Exp Med 185:247-252, 1998
77. Welch TR, Fryer C, Shely E, et al: Double-blind, controlled trial of short-term prednisone therapy in immunoglobulin A glomerulonephritis. J Pediatr 121:474-477, 1992
78. Hogg RJ: A randomized, placebo-controlled, multicenter trial evaluating alternate-day prednisone and fish oil supplements in young patients with immunoglobulin A nephropathy. Scientific Planning Committee of the IgA Nephropathy Study. Am J Kidney Dis 26:792-796, 1995
79. Hogg RJ, Lee JL, Nardelli N, et al: Multicenter, placebo-controlled trial of alternate-day prednisone (QOD-PRED) or daily omega-3 fatty acids (OM-3 FA) in children and young adults with IgA nephropathy (IgAN). Report from the Southwest Pediatric Nephrology Study Group [Abstract]. J Am Soc Nephrol 14:751A, 2003 (abstr)
80. Andreoli SP, Bergstein JM: Treatment of severe IgA nephropathy in children. Pediatr Nephrol 3:248-253, 1989
81. Yoshikawa N, Ito H, Sakai T, et al: For the Japanese Pediatric IgA Nephropathy Treatment Group: A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. J Am Soc Nephrol 10:101-109, 1999
82. Rasche FM, Schwarz A, Keller F: Tonsillectomy does not prevent a progressive course in IgA nephropathy. Clin Nephrol 3:147-152, 1999
83. Xie Y, Nishi S, Ueno M: The efficacy of tonsillectomy on long-tern survival in patients with IgA nephropathy. Kidney Int 63:1861-1867, 2003
84. Chan JC, Mahan JD, Trachtman H, et al: Vitamin E therapy in IgA nephropathy: A double-blind, placebo-controlled study. Pediatr Nephrol 18:1015-1019, 2003
85. D'Amico G: Natural history of idiopathic IgA nephropathy: Role of clinical and histological prognostic factors. Am J Kidney Dis 36:227-237, 2000
86. Levy M, Broyer M, Arsan A, et al: Anaphylactoid purpura nephritis in childhood: Natural history and immunopathology. Adv Nephrol 6:183-228, 1976
87. Nakamoto Y, Yoshihiro A, Dohi K, et al: Primary IgA glomerulonephritis and Schönlein-Henoch purpura nephritis: Clinicopathological and immunohistological characteristics. Q J Med 188:495-516, 1978
88. Waldo FB: Is Henoch-Schönlein purpura the systemic form of IgA nephropathy? Am J Kidney Dis 12:373-377, 1988
89. Meadow SR, Scott DG: Berger disease: Henoch-Schönlein syndrome without the rash. J Pediatr 106:27-31, 1985
90. Hughes FJ, Wolfish NM, McLaine PN: Henoch-Schönlein syndrome and IgA nephropathy: A case report suggesting a common pathogenesis. Pediatr Nephrol 2:389-392, 1988
91. Kaneko K, Suzuki Y, Kiya K, et al: A case report suggesting a common pathogenesis for IgA nephropathy and Henoch-Schönlein purpura. Pediatr Nephrol 8:750-751, 1994
92. Watanabe T, Takada T, Kihara I, et al: Three cases of Henoch-Schönlein purpura preceded by IgA nephropathy. Pediatr Nephrol 9:674, 1995
93. Stewart M, Savage JM, Bell B, et al: Long term renal prognosis of Henoch-Schönlein purpura in an unselected childhood population. Eur J Pediatr 147:113-115, 1988
94. Nielsen HE: Epidemiology of Schönlein-Henoch purpura. Acta Paediatr Scand 77:125-131, 1988
95. Calvino MC, Llorca J, Garcia-Porrua C, et al: Henoch-Schönlein purpura in children from northwestern Spain. A 20-year epidemiologic and clinical study. Medicine 80:279-290, 2001
96. Gardner-Medwin JM, Dolezalova P, Cummins C, et al: Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 360:1197-1202, 2002
97. Abdel-Al YK, Hejazi Z, Majeed HA: Henoch Schönlein purpura in Arab children. Analysis of 52 cases. Trop Geogr Med 42:52-57, 1990
98. al-Sheyyab M, el-Shanti H, Ajlouni S, et al: Henoch-Schönlein purpura: Clinical experience and contemplations on a streptococcal association. J Trop Pediatr 42:200-2003, 1996
99. Farley TA, Gillespie S, Rasoulpour M, et al: Epidemiology of a cluster of Henoch-Schönlein purpura. Am J Dis Child 143:798-803, 1989
100. Saulsbury FT: Henoch-Schönlein purpura in children: Report of 100 patients and review of the literature. Medicine 78:395-409, 1999
101. Heberden W: Commentari di morborium historia et curatione. London: Payne, 1801. Reprinted as "Commentaries on the History and Cure of Diseases." Birmingham, AL: The
102. Classics of Medicine Library, Division of Gryphon Editions, Ltd; 1982:395-397
103. Schonlein JL: Allgemeine und specielle Pathologie und therapie, vol 2 (3rd ed). Wurzburg 48, Herisau, 1837
104. Henoch E: Uber eine eigenthumliche form von purpura. Berl Klin Wochnschr 11:641-643, 1874
105. Henoch E: Vorlesungen uber kinderkrankheiten, in Hirschward, A, (ed): Vorlesuungen uber kinderkrankheiten, vol 10. Berlin, Aufl, 1899, pp 839
106. Osler W: Visceral lesions of purpura and allied conditions. BMJ 1:517-525, 1914
107. Mills JA, Michel BA, Bloch DA, et al: The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum 33:1114-1121, 1990
108. Michel BA, Hunder GG, Bloch DA, et al: Hypersensitivity vasculitis and Henoch-Schönlein purpura: A comparison between the two disorders. J Rheumatol 19:721-728, 1992
109. Evans DJ, Gwyn Williams D, Peters DK, et al: Glomerular deposition of properdin in Henoch-Schönlein syndrome and idiopathic focal nephritis. BMJ 11:326-328, 1973
110. Urizar RE, Michael A, Sisson S, et al: Anaphylactoid purpura II. Immunofluorescent and electron microscopy studies of the glomerular lesions. Lab Invest 19:437-440, 1968
111. Kobayashi O, Wada H, Okawa K, et al: Schönlein-Henoch's syndrome in children. Contrib Nephrol 40:250-254, 1977
112. West CD, McAdams AJ, Welch TR: Glomerulonephritis in Henoch-Schö nlein purpura without mesangial IgA deposition. Pediatr Nephrol 8:677-683, 1994
113. Heaton JM, Turner DR, Cameron JS: Localization of glomerular "deposits" in Henoch-Schönlein nephritis. Histopathology 1:93-104, 1977
114. Oliver TK Jr, Barnett HL: Incidence and prognosis of nephritis associated with anaphylactoid (Schönlein-Henoch purpura in children. Am J Dis Child 90:544-547, 1955
115. Wedgewood RJP, Klaus MH: Anaphylactoid purpura. A long term follow-up study with special reference to renal involvement. Pediatrics 16:196-206, 1955
116. Allen DM, Diamond LK, Howell DA: Anaphylactoid purpura in children (Schönlein-Henoch syndrome). Am J Dis Child 99:833-854, 1960
117. Koskimies O, Mir S, Rapola J, Vilska J: Henoch-Schönlein nephritis: Long-term prognosis of unselected patients. Arch Dis Child 56:482-484, 1981
118. Zurowska AM, Wrzolkowa T, Uszycka-Karcz M: Henoch-Schönlein nephritis in children-A clinicopathological study. Int J Pediatr Nephrol 6:183-188, 1985
119. Kaku Y, Nohara K, Honda S: Renal involvement in Henoch-Schönlein purpura: A multivariate analysis of prognostic features. Kidney Int 53:1755-1759, 1998
120. Sano H, Izumida M, Shimizu H, et al: Risk factors of renal involvement and significant proteinuria in Henoch-Schönlein purpura. Eur J Pediatr 161:196-201, 2002
121. Meadow SR, Glasgow EF, White RH, et al: Schönlein Henoch nephritis. Q J Med 41:241-258, 1972
122. Hurley RM, Drummond KN: Anaphylactoid purpura nephritis: Clinico-pathological correlations. J Pediatr 81:904-911, 1972
123. Counahan R, Winterbom MH, White RH, et al: Prognosis of Henoch-Schönlein nephritis in children. BMJ 2:11-14, 1977
124. Coppo R, Mazzucco G, Cagnoli L, et al: Long-term prognosis of Henoch Schönlein nephritis in adults and children. Nephrol Dial Transplant 12:2277-2283, 1997
125. Goodyer PR, de Chadarevian J-P, Kaplan BS: Acute poststreptococcal glomerulonephritis mimicking Henoch-Schönlein purpura. J Pediatr 93:412-415, 1978
126. Onisawa S, Morishima N, Ichimura T: Concurrent post-streptococcal acute glomerulonephritis and Schönlein-Henoch purpura. Acta Paediatr Jpn 31:487-492, 1989
127. Masuda M, Nakanishi N, Yoshizawa N, et al: Group A streptococcal antigen in the glomeruli of children with Henoch-Schönlein nephritis. Am J Kidney Dis 41:366-370, 2003
128. Bunchman TE, Mauer SM, Sibley RK, et al: Anaphylactoid purpura: Characteristics of 16 patients who progressed to renal failure. Pediatr Nephrol 2:393-397, 1988
129. Goldstein AR, White RHR, Akuse R, et al: Long-term follow-up of childhood Henoch-Schönlein purpura nephritis. Lancet 339:280-282, 1992
130. Scharer K, Krmar R, Querfeld U, et al: Clinical outcome of Schönlein-Henoch purpura nephritis in children. Pediatr Nephrol 13:816-823, 1999
131. Ronkainen J, Nututinen M, Koskimies O: The adult kidney 24 years after childhood Henoch-Schönlein purpura: A retrospective study. Lancet 360:666-670, 2002
132. Algoet C, Proesmans W: Renal biopsy 2-9 years after Henoch Schönlein purpura. Pediatr Nephrol 18:471-473, 2003
133. Pabunruang W, Treepongkaruna S, Tangnararatchakit K, et al: Henoch-Schönlein purpura: Clinical manifestations and long-term outcomes in Thai children. J Med Assoc Thai 85(suppl 4):S1213-S1218, 2002
134. Mestecky J, Tomana M, Crowley-Nowick PA, et al: Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib Nephrol 104:172-182, 1993
135. Tomana M, Matousovic K, Julian BA, et al: Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int 52:509-516, 1997
136. Saulsbury FT: Alterations in the O-linked glycosylation of IgA1 in children with Henoch-Schönlein purpura. J Rheumatol 24:2246-2249, 1997
137. Allen AC, Willis FR, Beattie TJ, et al: Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis. Nephrol Dial Transplant 13:990-994, 1998
138. Muller D, Greve D, Eggert P: Early tubular proteinuria and the development of nephritis in Henoch-Schönlein purpura. Pediatr Nephrol 15:85-89, 2000
139. Namgoong MK, Lim BK, Kim JS: Eosinophilic cationic protein in Henoch-Schönlein purpura and in lgA nephropathy. Pediatr Nephrol 11:703-706, 1997
140. Fujieda M, Oishi N, Naruse K, et al: Soluble thrombomodulin and antibodies to bovine glomerular endothelial cells in patients with Henoch-Schönlein purpura. Arch Dis Child 78:240-244, 1998
141. Besbas N, Saatci U, Ruacan S, et al: The role of cytokines in Henoch Schönlein purpura. Scand J Rheumatol 26:456-460, 1997
142. Muslu A, Islek I, Gok F, et al: Endothelin levels in Henoch-Schö nlein purpura. Pediatr Nephrol 17:920-925, 2002
143. White RHR: Henoch-Schönlein purpura nephritis: a disease with significant late sequelae. Nephron 68:1-9, 1994
144. Kumada K, Suzuki J, Kume K, et al: Clinicopathological study of Henoch-Schönlein purpura nephritis with special reference to C3c deposits. Nippon Jinzo Gakkai Shi 38:259-268, 1996
145. Amoroso A, Danek G, Vatta S, et al: Polymorphisms in angiotensin-converting enzyme gene and severity of renal disease in Henoch-Schönlein patients. Italian Group of Renal Immunopathology. Nephrol Dial Transplant 13:3184-3188, 1998
146. Brodkiewicz A, Ciechanowicz A, Urbanska A, et al: The I/D polymorphism of the ACE gene in children with Henoch-Schönlein purpura. Pol Merckuriusz Lex 8:236-238, 2000
147. Dudley J, Afifi E, Gardner A, et al: Polymorphism of the ACE gene in Henoch-Schönlein purpura nephritis. Pediatr Nephrol 14:218-220, 2000
148. Yoshioka T, Xu YX, Yoshida H, et al: Deletion polymorphism of the angiotensin converting enzyme gene predicts persistent proteinuria in Henoch-Schönlein purpura nephritis. Arch Dis Child 79:394-399, 1998
149. Amoli MM, Thomson W, Hajeer AH, et al: Interleukin I receptor antagonist gene polymorphism is associated with severe renal involvement and renal sequelae in Henoch-Schönlein purpura. J Rheumatol 29:1404-1407, 2002
150. Ault BH, Stapleton FB, Rivas ML, et al: Association of Henoch-Schönlein purpura glomerulonephritis and C4B deficiency. J Pediatr 117:753-755, 1990
151. Buchanec J, Galanda V, Belakova S, et al: Incidence of renal complications in Schönlein-Henoch purpura syndrome in dependence on an early administration of steroids. Int Urol Nephrol 20:409-412, 1988
152. Mollica F, Li Volti S, Garozzo R, et al: Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura. Eur J Pediatr 151:140-144, 1992
153. Saulsbury FT: Corticosteroid therapy does not prevent nephritis in Henoch-Schönlein purpura. Pediatr Nephrol 7:69-71, 1993
154. Oner A, Tinaztepe K, Erdogan O: The effect of triple therapy on rapidly progressive type of Henoch-Schönlein nephritis. Pediatr Nephrol 9:6-10, 1995
155. Niaudet P, Habib R: Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein-Henoch purpura nephritis. Pediatr Nephrol 12:238-243, 1998
156. Bergstein J, Leiser J, Andreoli SP: Response of crescentic Henoch-Schönlein purpura nephritis to corticosteroid and azathioprine therapy. Clin Nephrol 49:9-14, 1988
157. Iijima K, Ito-Kariya S, Nakamura H, et al: Multiple combined therapy for severe Henoch-Schönlein nephritis in children. Pediatr Nephrol 12:244-248, 1998
158. Hattori M, Ito K, Konomoto T, et al: Plasmapheresis as the sole therapy for rapidly progressive Henoch-Schönlein purpura nephritis in children. Am J Kid Dis 33:427-433, 1999
159. Tanaka H, Suzuki K, Nakahata T, Ito E, Waga S: Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis. Pediatr Nephrol 18:347-350, 2003
160. Foster BJ, Bernard C, Drummond KN, et al: Effective therapy for severe Henoch-Schönlein purpura nephritis with prednisone and azathioprine: A clinical and histopathologic study. J Pediatr 136:370-375, 2000
161. Watanabe T, Takahashi S, Nakajo S, et al: Pathological improvement of IgA nephropathy and Henoch-Schönlein purpura nephritis with urokinase therapy. Acta Paediatr Jpn 38:622-628, 1996
162. Kawasaki Y, Suzuki J, Nozawa R, et al: Efficacy of methylprednisolone and urokinase pulse therapy for severe Henoch-Schönlein nephritis. Pediatrics 111:785-789, 2003